251 results on '"Hungerford, J. L."'
Search Results
2. Tumours of the Eye and Orbit
3. Predicting local control of choroidal melanomas following 106Ru plaque brachytherapy
4. The success of primary chemotherapy for group D heritable retinoblastoma
5. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation
6. Retinoblastoma in Great Britain 1963–2002
7. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002
8. Trends in treatment and prognostic factors for conjunctival melanoma in a tertiary referral ocular oncology service over the last 50 years: 3336
9. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
10. Globe conserving treatment of the only eye in bilateral retinoblastoma
11. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window
12. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth
13. Differential immunoreactivity of melanocytic lesions of the conjunctiva
14. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma
15. Radiotherapy for ocular angiomas
16. Radioimmunoscintigraphy of Ocular Melanomas
17. Choroidal Metastasis from Follicular Cell Thyroid Carcinoma Masquerading as Circumscribed Choroidal Haemangioma
18. Whole-Eye versus Lens-Sparing Megavoltage Therapy for Retinoblastoma
19. Side Effects of Photon and Proton Radiotherapy for Ocular Melanoma
20. External beam radiotherapy for retinoblastoma: II. Lens sparing technique
21. The biology of micrometastases from uveal melanoma
22. Novel mutation in PANK2 associated with retinal telangiectasis
23. Predicting local control of choroidal melanomas following 106Ru plaque brachytherapy
24. Retinoblastoma in Great Britain 1963-2002
25. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002
26. The success of primary chemotherapy for group D heritable retinoblastoma
27. Malignant transformation of iris melanocytoma to iris ring melanoma
28. Presence and phenotype of dendritic cells in uveal melanoma
29. Oestrogen receptors in conjunctival malignant melanoma: immunocytochemical study using formalin fixed paraffin wax sections
30. Proton beam therapy and iris neovascularisation in uveal melanoma
31. Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas
32. Primary orbital melanoma masquerading as vascular anomalies
33. Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma
34. DELAY IN DIAGNOSIS OF RETINOBLASTOMA
35. Delay in diagnosis of retinoblastoma: risk factors and treatment outcome
36. P5 Ex vivo inhibition of melanoma by interferon alpha 2B (IFNα2b)
37. 03 Adjuvant alpha-interferon for high risk uveal melanoma—toxicity and trial recruitment issues
38. Modelling uveal melanoma
39. Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or Cytosine arabinoside
40. Ring melanoma---a rare cause of refractory glaucoma
41. The prognostic significance of c-myc oncogene expression in uveal melanoma
42. Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma
43. Reassessment of the PAS patterns in uveal melanoma
44. The Role of Cytology in the Diagnosis of Periocular Basal Cell Carcinomas
45. External beam radiotherapy for retinoblastoma: II. Lens sparing technique.
46. External beam radiotherapy for retinoblastoma: I. Whole eye technique.
47. Management of ocular melanoma
48. Cyclosporin-modulated chemotherapy with focal cryo/laser therapy
49. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma.
50. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.